Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.2 INR | +0.88% | -0.39% | +3.17% |
09:18am | Marksans Pharma Gets Marketing Approval for Levetiracetam Relonchem in UK | MT |
18/04 | Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.17% | 898M | |
+37.51% | 727B | |
-7.88% | 354B | |
+15.55% | 328B | |
-0.39% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.80% | 164B | |
-2.14% | 164B |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Transcript : Marksans Pharma Limited, Q2 2023 Earnings Call, Nov 16, 2022